Dynamic changes in HMGB1 levels correlate with inflammatory responses during cardiopulmonary bypass

  • Authors:
    • Zhiwei Zhang
    • Yuan Wu
    • Yuan Zhao
    • Xianzhong Xiao
    • Junwen Liu
    • Xinmin Zhou
  • View Affiliations

  • Published online on: March 22, 2013     https://doi.org/10.3892/etm.2013.1026
  • Pages: 1523-1527
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

High mobility group box 1 (HMGB1), which is released by activated immune cells and necrotic cells, has properties similar to those of pro-inflammatory cytokines. Cardiopulmonary bypass (CPB) induces systemic inflammation and aortic cross-clamping induces myocardial ischemia. This study was conducted to observe the dynamic changes of HMGB1 and tumor necrosis factor (TNF)-α levels during CPB and to analyze their clinical significance. A total of 78 cases of American Society of Anesthesiologists (ASA) grade II-IV undergoing elective valve replacement under CPB were included in this study. Blood and urine samples were collected after anesthesia prior to surgery (T1), before aortic cross-clamping (T2), after CPB (T3) and on the first day after surgery (T4), as well as the second (T5) and third (T6) day after surgery for determination of the levels of HMGB1, TNF-α, alanine aminotransferase (ALT), creatinine (Cr), blood urea nitrogen (BUN), N-acetyl-β-D-glucosamidase (NAG) and β2-microglobulin (β2-MG). Results revealed that: i) the serum levels of HMGB1 elevated as early as T1, increased until reaching a peak at T3, then decreased to a lower level at T4; ii) the serum level of TNF-α was low at T1, gradually increased in a similar manner to HMGB1, then decreased following CPB and reached the lowest point at T5; and iii) the levels of HMGB1 were positively correlated with serum TNF-α and serum ALT at T3. In conclusion, HMGB1 levels may be used as an indicator of inflammation and may be a novel target for controlling inflammation during CPB. The optimal treatment time is T3 (after CPB).
View Figures
View References

Related Articles

Journal Cover

May 2013
Volume 5 Issue 5

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang Z, Wu Y, Zhao Y, Xiao X, Liu J and Zhou X: Dynamic changes in HMGB1 levels correlate with inflammatory responses during cardiopulmonary bypass. Exp Ther Med 5: 1523-1527, 2013
APA
Zhang, Z., Wu, Y., Zhao, Y., Xiao, X., Liu, J., & Zhou, X. (2013). Dynamic changes in HMGB1 levels correlate with inflammatory responses during cardiopulmonary bypass. Experimental and Therapeutic Medicine, 5, 1523-1527. https://doi.org/10.3892/etm.2013.1026
MLA
Zhang, Z., Wu, Y., Zhao, Y., Xiao, X., Liu, J., Zhou, X."Dynamic changes in HMGB1 levels correlate with inflammatory responses during cardiopulmonary bypass". Experimental and Therapeutic Medicine 5.5 (2013): 1523-1527.
Chicago
Zhang, Z., Wu, Y., Zhao, Y., Xiao, X., Liu, J., Zhou, X."Dynamic changes in HMGB1 levels correlate with inflammatory responses during cardiopulmonary bypass". Experimental and Therapeutic Medicine 5, no. 5 (2013): 1523-1527. https://doi.org/10.3892/etm.2013.1026